Verge Genomics

Verge Genomics has developed an advanced all-in-human AI-powered platform to expedite the process of discovering new drugs.

Headquarters

Year Founded

Company Status

Website

Sector

Operating Status

Social Media

Search Tags

AI drug discovery, biotechnology innovation, artificial intelligence in medicine

About Us

Verge Genomics is a biotechnology company that uses artificial intelligence and human genomic data to discover and develop new drugs for complex diseases. They have a proprietary platform called that analyzes patient tissue data to identify potential drug targets.

Trending Companies in AI

Latest Articles in AI

Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >
Anycubic Photon Mono M7 Pro for $469 with code AC30OFF. FREE $99 Gifts: 1*High Speed Resin+2*FEP Film+3000pcs Limited Mystery Box

CREATORS. DISRUPTORS. INNOVATORS.

Discover Emerging Technology Companies